FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Josep Font

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Enzyme-Linked Immunosorbent Assay

Anatomy

Thrombosis

Co-author Network

Publications

TOP 3
Frédéric A Houssiau; carlos vasconcelos; David D'Cruz; gian domenico sebastiani; Enrique de Ramon Garrido; Maria Giovanna Danieli; D Abramovicz; Daniel Blockmans; A Cauli; Haner Direskeneli; Mauro Galeazzi; A Gül; Y Levy; P Petera; Rajko Popovic; Radmila Petrovic; renato alberto sinico; R Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
gian domenico sebastiani; Gabriella Morozzi; Francesca Bellisai; Irene Fineschi; Maria Romana Bacarelli; Antonella Simpatico; Josep Font; Ricard Cervera; Frederic Houssiau; Antonio Fernandez-Nebro; Enrique de Ramon Garrido; Ornella De Pità; Josef Smolen; Mauro Galeazzi
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations.
Manuel Ramos-Casals; Xavier Forns; Pilar Brito-Zerón; A Vargas; M Ruiz; Montserrat Laguno; Jordi Yagüe; José M Sánchez-Tapias; José M Gatell; Josep Font
Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Josep Font (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Frédéric A Houssiau; carlos vasconcelos; David D'Cruz; gian domenico sebastiani; Enrique de Ramon Garrido; Maria Giovanna Danieli; D Abramovicz; Daniel Blockmans; A Cauli; Haner Direskeneli; Mauro Galeazzi; A Gül; Y Levy; P Petera; Rajko Popovic; Radmila Petrovic; renato alberto sinico; R Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
Annals of the rheumatic diseases 2010;69(1):61-4.
2008: gian domenico sebastiani; Gabriella Morozzi; Francesca Bellisai; Irene Fineschi; Maria Romana Bacarelli; Antonella Simpatico; Josep Font; Ricard Cervera; Frederic Houssiau; Antonio Fernandez-Nebro; Enrique de Ramon Garrido; Ornella De Pità; Josef Smolen; Mauro Galeazzi
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations.
Immunological investigations 2008;37(4):375-85.
2007: Manuel Ramos-Casals; Xavier Forns; Pilar Brito-Zerón; A Vargas; M Ruiz; Montserrat Laguno; Jordi Yagüe; José M Sánchez-Tapias; José M Gatell; Josep Font
Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.
Journal of viral hepatitis 2007;14(10):736-42.
2007: Pilar Brito-Zerón; Manuel Ramos-Casals; A Bove; J Sentis; Josep Font
Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors.
Rheumatology (Oxford, England) 2007;46(8):1359-62.
2007: Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
Lessons from diseases mimicking Sjögren's syndrome.
Clinical reviews in allergy & immunology 2007;32(3):275-83.
2007: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Ronald A Asherson; Mario García-Carrasco; Izaias P da Costa; Danieli C O Andrade; Eduardo F Borba; Alexander Makatsaria; Silvia Bucciarelli; Manuel Ramos-Casals; Josep Font
Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases.
Annals of the rheumatic diseases 2007;66(6):740-6.
2007: Manuel Ramos-Casals; Pilar Brito-Zerón; Antoni Sisó; Alfonso Vargas; Emilio Ros; Albert Bove; Rafael Belenguer; Joan Plaza; Jaume Benavent; Josep Font
High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
The Journal of rheumatology 2007;34(4):754-61.
2007: Ricard Cervera; Gerard Espinosa; Aida Cordero; M Rosa Oltra; Ainhoa Unzurrunzaga; Tomeu Rossiñol; Joan Plaza; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Ronald A Asherson; Josep Font
Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS.
Seminars in arthritis and rheumatism 2007;36(5):287-96.
2007: Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
Seminars in arthritis and rheumatism 2007;36(4):246-55.
2007: Mario García-Carrasco; C Galarza; M Gómez-Ponce; Ricard Cervera; Jorge Rojas-Rodríguez; Gerard Espinosa; Silvia Bucciarelli; José A Gómez-Puerta; Albert Bové; Ricardo O Escárcega; Josep Font
Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients.
Lupus 2007;16(5):366-73.
2007: Josep Font; Manuel Ramos-Casals; Pilar Brito-Zerón; Norma Nardi; A Ibañez; Belen Suarez; Sònia Jiménez; Dolors Tàssies; Angeles García-Criado; Emilio Ros; J Sentís; Joan Carles Reverter; Francisco Lozano
Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
Rheumatology (Oxford, England) 2007;46(1):76-80.
2006: Wolfgang Miesbach; Ronald A Asherson; Ricard Cervera; Y Shoenfeld; J Gomez Puerta; Silvia Bucciarelli; G Espinoza; Josep Font
The catastrophic antiphospholipid (Asherson's) syndrome and malignancies.
Autoimmunity reviews 2006;6(2):94-7.
2006: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; Josep Font
Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome.
Autoimmunity reviews 2006;6(2):85-8.
2006: Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; José A Gómez-Puerta; Josep Font
Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry.
Autoimmunity reviews 2006;6(2):81-4.
2006: Silvia Bucciarelli; Ricard Cervera; Gerard Espinosa; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.
Autoimmunity reviews 2006;6(2):72-5.
2006: Gerard Espinosa; Silvia Bucciarelli; Ricard Cervera; José A Gómez-Puerta; Josep Font
Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome.
Autoimmunity reviews 2006;6(2):68-71.
2006: Manuel Ramos-Casals; Angel Robles; Pilar Brito-Zerón; Norma Nardi; José M Nicolás; Xavier Forns; Joan Plaza; Jordi Yagüe; José M Sánchez-Tapias; Josep Font
Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases.
Seminars in arthritis and rheumatism 2006;36(3):189-96.
2006: Ricard Cervera; Josep Font; Yehuda Shoenfeld
European Working Party on Systemic Lupus Erythematosus: a 15-year report.
Autoimmunity reviews 2006;5(8):549-53.
2006: Ricard Cervera; Josep Font; Angela Tincani; Marie-Claire Boffa
V meeting of the European forum on antiphospholipid antibodies.
Autoimmunity reviews 2006;5(7):499-507.
2006: Manuel Ramos-Casals; José M Sánchez-Tapias; Albert Pares; Xavier Forns; Pilar Brito-Zerón; Norma Nardi; Pilar Vazquez; Desirée Vélez; Isabel Arias; Albert Bové; Joan Plaza; Juan Rodés; Josep Font
Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.
The Journal of rheumatology 2006;33(8):1593-9.
2006: Ricard Cervera; Ronald A Asherson; Josep Font
Catastrophic antiphospholipid syndrome.
Rheumatic diseases clinics of North America 2006;32(3):575-90.
2006: Silvia Bucciarelli; Gerard Espinosa; Ricard Cervera; Doruk Erkan; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font; Ronald A Asherson
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.
Arthritis and rheumatism 2006;54(8):2568-76.
2006: José A Gómez-Puerta; Gerard Espinosa; José M Miró; Omar Sued; Josep M Llibre; Ricard Cervera; Josep Font
Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.
The Israel Medical Association journal : IMAJ 2006;8(7):513-4.
2006: Norma Nardi; Pilar Brito-Zerón; Manuel Ramos-Casals; Sira Aguiló; Ricard Cervera; Miguel Ingelmo; Josep Font
Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.
Clinical rheumatology 2006;25(3):341-6.
2006: Pilar Brito-Zerón; Manuel Ramos-Casals; Norma Nardi; Josep Font
[Results of the treatment with oral pilocarpine in 100 patients with primary Sjögrens syndrome].
Medicina clínica 2006;126(16):637.
2006: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Sira Aguiló; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Ronald A Asherson; Josep Font
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.
Seminars in arthritis and rheumatism 2006;35(5):322-32.
2006: Manuel Ramos-Casals; Norma Nardi; Pilar Brito-Zerón; Sira Aguiló; Victor Gil; German Delgado; Albert Bové; Josep Font
Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
Seminars in arthritis and rheumatism 2006;35(5):312-21.
2006: Manuel Ramos-Casals; Norma Nardi; Mariana Lagrutta; Pilar Brito-Zerón; Albert Bové; German Delgado; Ricard Cervera; Miguel Ingelmo; Josep Font
Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients.
Medicine 2006;85(2):95-104.
2006: X Bosch; A Guilabert; Lucio Pallarés; R Cerveral; Manuel Ramos-Casals; Albert Bové; Miguel Ingelmo; Josep Font
Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients.
Lupus 2006;15(9):584-9.
2006: Jose A. Gomez-Puerta; E Salgado; Ricard Cervera; S Aguilo; Manuel Ramos-Casals; M Soler; A Torras; Josep Font
Catastrophic antiphospholipid syndrome presenting with renal thrombotic microangiopathy and diffuse proliferative glomerulonephritis.
Clinical and experimental rheumatology 2006;24(1):110.
2005: José A Gómez-Puerta; Jorge Musuruana; Carlos Saez; Ricard Cervera; Josep Font
[Sarcoidosis as seronegative spondyloarthropathy].
Biomédica : revista del Instituto Nacional de Salud 2005;25(4):435-8.
2005: Manuel Ramos-Casals; Albert Pares; L-J Jara; R Solans; O Viñas; P Vázquez; José M Sánchez-Tapias; J Rodés; Josep Font
Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature.
Journal of viral hepatitis 2005;12(6):648-54.
2005: Manuel Ramos-Casals; Josep Font
Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts.
Rheumatology (Oxford, England) 2005;44(11):1354-67.
2005: Ricard Cervera; Josep Font; José A Gómez-Puerta; Gerard Espinosa; M Cucho; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Jean-Charles Piette; Yehuda Shoenfeld; Ronald A Asherson
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.
Annals of the rheumatic diseases 2005;64(8):1205-9.
2005: Gerard Espinosa; Juan I Arostegui; Susana Plaza; Josefa Rius; Ricard Cervera; Jordi Yagüe; Josep Font
Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship?
Clinical and experimental rheumatology 2005;23(4 Suppl 38):S64-6.
2005: Manuel Ramos-Casals; Josep Font
Extrahepatic manifestations in patients with chronic hepatitis C virus infection.
Current opinion in rheumatology 2005;17(4):447-55.
2005: Felix Perez-Villa; Josep Font; Manel Azqueta; Gerard Espinosa; Carles Pare; Ricard Cervera; Joan Carles Reverter; Miguel Ingelmo; Gines Sanz
Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.
Arthritis and rheumatism 2005;53(3):460-7.
2005: Manuel Ramos-Casals; L-J Jara; Francisco Medina; José Rosas; Jaime Calvo-Alen; J Mañá; Juan-Manuel Anaya; Josep Font
Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
Journal of internal medicine 2005;257(6):549-57.
2005: Ronald A Asherson; Gerard Espinosa; Ricard Cervera; José A Gómez-Puerta; J Musuruana; Silvia Bucciarelli; Manuel Ramos-Casals; A L Martínez-González; Miguel Ingelmo; Joan Carles Reverter; Josep Font; Douglas A Triplett
Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
Annals of the rheumatic diseases 2005;64(6):943-6.
2005: Sònia Jiménez; M Angels García-Criado; Dolors Tàssies; Joan Carles Reverter; Ricard Cervera; M Rosa Gilabert; Daniel Zambón; Emilio Ros; Concepció Bru; Josep Font
Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.
Rheumatology (Oxford, England) 2005;44(6):756-61.
2005: R Belenguer; Manuel Ramos-Casals; Pilar Brito-Zerón; J del Pino; J Sentís; Sira Aguiló; Josep Font
Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome.
Clinical and experimental rheumatology 2005;23(3):351-6.
2005: Pilar Brito-Zerón; Manuel Ramos-Casals; Norma Nardi; Ricard Cervera; Jordi Yagüe; Miguel Ingelmo; Josep Font
Circulating monoclonal immunoglobulins in Sjögren syndrome: prevalence and clinical significance in 237 patients.
Medicine 2005;84(2):90-7.
2005: Manuel Ramos-Casals; Véronique Loustaud-Ratti; Salvatore De Vita; Margit Zeher; Jose-Angel Bosch; Eric Toussirot; Francisco Medina; José Rosas; Juan-Manuel Anaya; Josep Font
Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases.
Medicine 2005;84(2):81-9.
2005: Manuel Ramos-Casals; Juan Mañá; Norma Nardi; Pilar Brito-Zerón; Antoni Xaubet; José M Sánchez-Tapias; Ricard Cervera; Josep Font
Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases.
Medicine 2005;84(2):69-80.
2005: Manuel Ramos-Casals; Athanasios G Tzioufas; Josep Font
Primary Sjögren's syndrome: new clinical and therapeutic concepts.
Annals of the rheumatic diseases 2005;64(3):347-54.
2005: Manuel Ramos-Casals; Athanasios G Tzioufas; Josep Font
[Sjögren syndrome. New therapeutic approaches].
Medicina clínica 2005;124(3):111-5.
2005: Manuel Ramos-Casals; Josep Font
Mycophenolate mofetil in patients with hepatitis C virus infection.
Lupus 2005;14 Suppl 1():s64-72.
2005: Manuel Ramos-Casals; Pilar Brito-Zerón; Jordi Yagüe; M Akasbi; R Bautista; M Ruano; Gisela Claver; Victor Gil; Josep Font
Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Rheumatology (Oxford, England) 2005;44(1):89-94.
2005: José A Gómez-Puerta; Ricard Cervera; L M Calvo; Beatriz Gómez-Ansón; Gerard Espinosa; Gisela Claver; Silvia Bucciarelli; Albert Bové; Manuel Ramos-Casals; Miguel Ingelmo; Josep Font
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.
Rheumatology (Oxford, England) 2005;44(1):95-9.
2004: Frédéric A Houssiau; carlos vasconcelos; David D'Cruz; gian domenico sebastiani; Enrique de Ramon Garrido; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; renato alberto sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Arthritis and rheumatism 2004;50(12):3934-40.
2004: Manuel Ramos-Casals; Pilar Brito-Zerón; Norma Nardi; Gisela Claver; G Risco; F-D Parraga; S Fernandez; M Julià; Josep Font
Successful treatment of severe Raynaud's phenomenon with bosentan in four patients with systemic sclerosis.
Rheumatology (Oxford, England) 2004;43(11):1454-6.
2004: Ricard Cervera; Ronald A Asherson; M L Acevedo; José A Gómez-Puerta; Gerard Espinosa; Gloria de la Red; Victor Gil; Manuel Ramos-Casals; Mario García-Carrasco; Miguel Ingelmo; Josep Font
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.
Annals of the rheumatic diseases 2004;63(10):1312-7.
2004: Manuel Ramos-Casals; Pilar Brito-Zerón; Alfonso López-Soto; Josep Font
Systemic autoimmune diseases in elderly patients: atypical presentation and association with neoplasia.
Autoimmunity reviews 2004;3(5):376-82.
2004: Gerard Espinosa; Silvia Bucciarelli; Ricard Cervera; M Lozano; Joan Carles Reverter; Gloria de la Red; Victor Gil; Miguel Ingelmo; Josep Font; Ronald A Asherson
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.
Annals of the rheumatic diseases 2004;63(6):730-6.
2004: Manuel Ramos-Casals; Josep Font; P Brito-Zeron; Olga Trejo; Mario García-Carrasco; F Lozano
Interleukin-4 receptor alpha polymorphisms in primary Sjögren's syndrome.
Clinical and experimental rheumatology 2004;22(3):374.
2004: Manuel Ramos-Casals; Ricard Cervera; Mariana Lagrutta; Francisco Medina; Mario García-Carrasco; Gloria de la Red; Albert Bové; Miguel Ingelmo; Josep Font
Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(7):1009-16.
2004: Manuel Ramos-Casals; Juan-Manuel Anaya; Mario García-Carrasco; José Rosas; Albert Bové; Gisela Claver; Luis-Aurelio Diaz; Carmen Herrero; Josep Font
Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients.
Medicine 2004;83(2):96-106.
2004: Manuel Ramos-Casals; Pilar Brito-Zerón; Mario García-Carrasco; Josep Font
Sarcoidosis or Sjögren syndrome? Clues to defining mimicry or coexistence in 59 cases.
Medicine 2004;83(2):85-95.
2004: Manuel Ramos-Casals; Olga Trejo; Mario García-Carrasco; Ricard Cervera; Gloria de la Red; Victor Gil; Armando López-Guillermo; Miguel Ingelmo; Josep Font
Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
The Journal of rheumatology 2004;31(3):495-9.
2004: Josep Font; Ricard Cervera; Manuel Ramos-Casals; Mario García-Carrasco; Juan Sents; Carme Herrero; Jose-Antonio del Olmo; Alexandre Darnell; Miguel Ingelmo
Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center.
Seminars in arthritis and rheumatism 2004;33(4):217-30.
2004: Manuel Ramos-Casals; M T Campoamor; A Chamorro; G Salvador; S Segura; J C Botero; Jordi Yagüe; Ricard Cervera; Miguel Ingelmo; Josep Font
Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
Lupus 2004;13(10):777-83.
2004: Silvia Bucciarelli; Ricard Cervera; M Martínez; Xavier Latorre; Josep Font
Susac's syndrome or catastrophic antiphospholipid syndrome?
Lupus 2004;13(8):607-8.
2004: José A Gómez-Puerta; Victor Gil; Ricard Cervera; R Miquel; S Jiménez; Manuel Ramos-Casals; Josep Font
Coeliac disease associated with systemic sclerosis.
Annals of the rheumatic diseases 2004;63(1):104-5.
2003: Ricard Cervera; Munther A Khamashta; Josep Font; gian domenico sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric A Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; G R V Hughes
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
Medicine 2003;82(5):299-308.
2003: Olga Trejo; Manuel Ramos-Casals; Armando López-Guillermo; Mario García-Carrasco; Jordi Yagüe; Ricard Cervera; Josep Font; Miguel Ingelmo
Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Seminars in arthritis and rheumatism 2003;33(1):19-28.
2003: Sònia Jiménez; Ricard Cervera; Josep Font; Miguel Ingelmo
The epidemiology of systemic lupus erythematosus.
Clinical reviews in allergy & immunology 2003;25(1):3-12.
2003: Josep Font; Manuel Ramos-Casals; Gloria de la Red; Adolf Pou; Arnau Casanova; Mario García-Carrasco; Ricard Cervera; José A Molina; Josep Valls; Albert Bové; Miguel Ingelmo; Francesc Graus
Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature.
The Journal of rheumatology 2003;30(7):1552-7.
2003: Manuel Ramos-Casals; Olga Trejo; Mario García-Carrasco; Josep Font
Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection.
Rheumatology (Oxford, England) 2003;42(7):818-28.
2003: Ricard Cervera; Octavi Viñas; Manuel Ramos-Casals; Josep Font; Mario García-Carrasco; Antoni Sisó Almirall; F Ramírez; Y Machuca; Jordi Vives; Miguel Ingelmo; R W Burlingame
Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.
Annals of the rheumatic diseases 2003;62(5):431-4.
2003: Gerard Espinosa; Ricard Cervera; Josep Font; Yehuda Shoenfeld
Antiphospholipid syndrome: pathogenic mechanisms.
Autoimmunity reviews 2003;2(2):86-93.
2003: Gerard Espinosa; Eugénia Santos; Ricard Cervera; Jean-Charles Piette; Gloria de la Red; Victor Gil; Josep Font; Robert Couch; Miguel Ingelmo; Ronald A Asherson
Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients.
Medicine 2003;82(2):106-18.
2003: Manuel Ramos-Casals; Mario García-Carrasco; Francisco López-Medrano; Olga Trejo; Xavier Forns; Armando López-Guillermo; Carles Muñoz; Miguel Ingelmo; Josep Font
Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases.
Medicine 2003;82(2):87-96.
2003: Gerard Espinosa; Ricard Cervera; Josep Font; Ronald A Asherson
Adrenal involvement in the antiphospholipid syndrome.
Lupus 2003;12(7):569-72.
2003: Manuel Ramos-Casals; Mario García-Carrasco; Maria-Pilar Brito; A López-Soto; Josep Font
Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly.
Lupus 2003;12(5):341-55.
2002: Ricard Cervera; Josep Font; Francisco Carmona; Juan Balasch
Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium.
Autoimmunity reviews 2002;1(6):354-9.
2002: Josep Font; Gerard Espinosa; Dolors Tàssies; Marc Pino; Munther A Khamashta; Teresa Gallart; Ricard Cervera; Gines Escolar; G R V Hughes; Miguel Ingelmo; Antonio Ordinas; Joan Carles Reverter
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions.
Arthritis and rheumatism 2002;46(12):3283-9.
2002: Josep Font; Manuel Ramos-Casals
[Current therapy of lupus nephritis].
Medicina clínica 2002;119(19):738-42.
2002: Sònia Jiménez; Josep Font; Miguel Ingelmo
[Systemic lupus erythematosus and cardiovascular disease].
Medicina clínica 2002;119(18):699-706.
2002: Josep Font; Manuel Ramos-Casals; A P Vilas; Mario García-Carrasco; Maria-Pilar Brito; Gloria de la Red; Victor Gil; A García-Carrasco; Ricard Cervera; Miguel Ingelmo
Low values of creatine kinase in systemic lupus erythematosus. Clinical significance in 300 patients.
Clinical and experimental rheumatology 2002;20(6):837-40.
2002: Josep Font; Mario García-Carrasco; Manuel Ramos-Casals; Anna Aldea; Ricard Cervera; Miguel Ingelmo; Jordi Vives; Jordi Yagüe
The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome.
Rheumatology (Oxford, England) 2002;41(9):1025-30.
2002: Manuel Ramos-Casals; Mario García-Carrasco; Maria Pilar Brito Zerón; Ricard Cervera; Josep Font
Viral etiopathogenesis of Sjögren's syndrome: role of the hepatitis C virus.
Autoimmunity reviews 2002;1(4):238-43.
2002: Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; Xavier Filella; Olga Trejo; Gloria de la Red; Victor Gil; José M Sánchez-Tapias; Josep Font; Miguel Ingelmo
Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection.
Seminars in arthritis and rheumatism 2002;32(1):56-63.
2002: Frédéric A Houssiau; carlos vasconcelos; David D'Cruz; gian domenico sebastiani; Enrique de Ramon Garrido Ed; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; renato alberto sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Arthritis and rheumatism 2002;46(8):2121-31.
2002: Gerard Espinosa; Josep Font; FJ Muñoz-Rodríguez; Ricard Cervera; Miguel Ingelmo
Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?
Clinical rheumatology 2002;21(4):309-13.
2002: Gerard Espinosa; Ricard Cervera; Joan Carles Reverter; Dolors Tàssies; Josep Font; Miguel Ingelmo
Vascular involvement in Behçet's disease.
The Israel Medical Association journal : IMAJ 2002;4(8):614-6.
2002: Manuel Ramos-Casals; Josep Font; Mario Garcia-Carrasco; Maria-Pilar Brito; José Rosas; Jaime Calvo-Alen; Lucio Pallares; Ricard Cervera; Miguel Ingelmo
Primary Sjögren syndrome: hematologic patterns of disease expression.
Medicine 2002;81(4):281-92.
2002: Mario García-Carrasco; Manuel Ramos-Casals; José Rosas; Lucio Pallarés; Jaime Calvo-Alen; Ricard Cervera; Josep Font; Miguel Ingelmo
Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients.
Medicine 2002;81(4):270-80.
2002: Ronald A Asherson; Gerard Espinosa; Ricard Cervera; Josep Font; Joan Carles Reverter
Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2002;8(3):157-65.
2002: Francisco López-Medrano; Ricard Cervera; Olga Trejo; Josep Font; Miguel Ingelmo
Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level.
Annals of the rheumatic diseases 2002;61(6):562-3.
2002: Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; R H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric A Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; carlos vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; G R V Hughes; Miguel Ingelmo
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Arthritis and rheumatism 2002;46(4):1019-27.
2002: Mario García-Carrasco; Antoni Sisó Almirall; Manuel Ramos-Casals; José Rosas; Gloria de la Red; Victor Gil; Susana Lasterra; Ricard Cervera; Josep Font; Miguel Ingelmo
Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients.
The Journal of rheumatology 2002;29(4):726-30.
2002: Gerard Espinosa; Ricard Cervera; Josep Font; Ronald A Asherson
The lung in the antiphospholipid syndrome.
Annals of the rheumatic diseases 2002;61(3):195-8.
2002: FJ Muñoz-Rodríguez; Joan Carles Reverter; Josep Font; Dolors Tàssies; Gerard Espinosa; Ricard Cervera; Francisco Carmona; J Balsch; Miguel Ingelmo; Antonio Ordinas
Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
Lupus 2002;11(11):730-5.
2002: Gerard Espinosa; Josep Font; Dolors Tàssies; Antonio Vidaller; Ramon Deulofeu; Alfonso López-Soto; Ricard Cervera; Antonio Ordinas; Miguel Ingelmo; Joan Carles Reverter
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
The American journal of medicine 2002;112(1):37-43.
2001: R A Asherson; Ricard Cervera; J C Piette; Y Shoenfeld; Gerard Espinosa; Michelle Petri; E Lim; T C Lau; A Gurjal; Anna Jedryka-Góral; Hanna Chwalinska-Sadowska; R J Dibner; Jorge Rojas-Rodríguez; Mario García-Carrasco; J T Grandone; A L Parke; P Barbosa; carlos vasconcelos; Manuel Ramos-Casals; Josep Font; Miguel Ingelmo
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients.
Medicine 2001;80(6):355-77.
2001: Gerard Espinosa; Josep Font; J C García-Pagan; Dolors Tàssies; Joan Carles Reverter; Carles Gaig; Francisco Cervantes; Ricard Cervera; Jaime Bosch; Miguel Ingelmo
Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.
Medicine 2001;80(6):345-54.
2001: O Arranz; Jordi Ara; R Rodriguez; L Quintó; Josep Font; Eduard Mirapeix; Alejandro Darnell
Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients.
Clinical nephrology 2001;56(4):295-301.
2001: Manuel Ramos-Casals; Mario Garcia-Carrasco; Ricard Cervera; Josep Font
Is hepatitis C virus a sialotropic virus?
The American journal of pathology 2001;159(4):1593-4.
2001: Manuel Ramos-Casals; Josep Font; M García-Carrasco; Javier Calvo; Lourdes Places; Olga Padilla; Ricard Cervera; MA Bowen; Francisco Lozano; Miguel Ingelmo
High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome.
Rheumatology (Oxford, England) 2001;40(9):1056-9.
2001: Gerard Espinosa; Dolors Tàssies; Josep Font; FJ Muñoz-Rodríguez; Ricard Cervera; Antonio Ordinas; Joan Carles Reverter; Miguel Ingelmo
Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis.
Seminars in arthritis and rheumatism 2001;31(1):12-20.
2001: Carlos Miret; Josep Font; Rafael Molina; Mario Garcia-Carrasco; Xavier Filella; M Ramos; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Anticancer research 2001;21(4B):3053-9.
2001: M Garcíc-Carrasco; Josep Font; X Filella; Ricard Cervera; Manuel Ramos-Casals; Antoni Sisó Almirall; A Aymamí; A M Ballesta; Miguel Ingelmo
Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features.
Clinical and experimental rheumatology 2001;19(4):411-5.
2001: Olga Trejo; Manuel Ramos-Casals; Mario García-Carrasco; Jordi Yagüe; Sònia Jiménez; Gloria de la Red; Ricard Cervera; Josep Font; Miguel Ingelmo
Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center.
Medicine 2001;80(4):252-62.
2001: Manuel Ramos-Casals; Josep Font; Miguel Ingelmo
[Prevalence and clinical significance of hepatitis C virus infection in systemic autoimmune diseases].
Medicina clínica 2001;116(18):701-9.
2001: Mario García-Carrasco; Manuel Ramos-Casals; Ricard Cervera; Olga Trejo; Jordi Yagüe; Antoni Sisó Almirall; Sònia Jiménez; Gloria de la Red; Josep Font; Miguel Ingelmo
Cryoglobulinemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients.
Seminars in arthritis and rheumatism 2001;30(5):366-73.
2001: Jordi Ara; Eduard Mirapeix; Pilar Arrizabalaga; R Rodriguez; Carlos Ascaso; Rosa Abellana; Josep Font; Alejandro Darnell
Circulating soluble adhesion molecules in ANCA-associated vasculitis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(2):276-85.
2001: Ricard Cervera; Munther A Khamashta; Josep Font; G R V Hughes
European Working Party on Systemic Lupus Erythematosus: a 10 year report.
Lupus 2001;10(12):892-4.
2001: Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; José Rosas; Olga Trejo; Gloria de la Red; José M Sánchez-Tapias; Josep Font; Miguel Ingelmo
Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases.
Medicine 2001;80(1):1-8.
2001: Josep Font; Manuel Ramos-Casals; Ricard Cervera; Mario García-Carrasco; A Torras; Antoni Sisó Almirall; A Darnell; Miguel Ingelmo
Cardiovascular risk factors and the long-term outcome of lupus nephritis.
QJM : monthly journal of the Association of Physicians 2001;94(1):19-26.
2000: Manuel Ramos-Casals; Josep Font; Mario García-Carrasco; Ricard Cervera; S Jiménez; Olga Trejo; Gloria de la Red; José M Sánchez-Tapias; Miguel Ingelmo
Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus.
Arthritis and rheumatism 2000;43(12):2801-6.
2000: Josep Font; S Jiménez; Ricard Cervera; Mario García-Carrasco; Manuel Ramos-Casals; J Campdelacreu; Miguel Ingelmo
Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases.
Annals of the rheumatic diseases 2000;59(11):920-3.
2000: Dolors Tàssies; Gerard Espinosa; FJ Muñoz-Rodríguez; Carolina Freire; Ricard Cervera; Joan Monteagudo; Santiago Maragall; Gines Escolar; Miguel Ingelmo; Antonio Ordinas; Josep Font; Joan Carles Reverter
The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
Arthritis and rheumatism 2000;43(10):2349-58.
2000: Gerard Espinosa; FJ Muñoz-Rodríguez; Ricard Cervera; Josep Font
[The etiopathogenic role of hepatitis virus C in the antiphospholipid syndrome].
Medicina clínica 2000;115(9):357-8.
2000: Manuel Ramos-Casals; Ricard Cervera; Mario García-Carrasco; J Vidal; Olga Trejo; Sònia Jiménez; J Costa; Josep Font; Miguel Ingelmo
Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome.
Seminars in arthritis and rheumatism 2000;29(6):373-8.
2000: FJ Muñoz-Rodríguez; Joan Carles Reverter; Josep Font; Dolors Tàssies; Ricard Cervera; Gerard Espinosa; Francisco Carmona; J Balasch; Antonio Ordinas; Miguel Ingelmo
Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Haematologica 2000;85(6):632-7.
2000: Mario García-Carrasco; Pilar Pizcueta; Ricard Cervera; Manuel Ramos-Casals; Antoni Sisó Almirall; Gloria de la Red; Miguel Ingelmo; Josep Font; Pablo Engel
Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome.
Annals of the rheumatic diseases 2000;59(4):297-9.
2000: Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; J Gaya; I Halperin; I Ubieto; A Aymamí; RM Morlà; Josep Font; Miguel Ingelmo
Thyroid disease in primary Sjögren syndrome. Study in a series of 160 patients.
Medicine 2000;79(2):103-8.
2000: Manuel Ramos-Casals; Olga Trejo; Mario García-Carrasco; Ricard Cervera; Josep Font
Mixed cryoglobulinemia: new concepts.
Lupus 2000;9(2):83-91.
2000: Mauro Galeazzi; gian domenico sebastiani; Angela Tincani; Jean-Charles Piette; Flavio Allegri; Gabriella Morozzi; Francesca Bellisai; Raffaella Scorza; Giovanni Battista Ferrara; Carlo Carcassi; Josep Font; Giuseppe Passiu; Josef Smolen; Chryssa Papasteriades; Frédéric A Houssiau; A F Nebro; E D Ramon Garrido; Anna Jedryka-Goral; Roberto Marcolongo
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.
Lupus 2000;9(1):47-55.
2000: Ricard Cervera; Josep Font; Manuel Ramos-Casals; Mario García-Carrasco; José Rosas; RM Morlà; F J Muñoz; A Artigues; Lucio Pallarés; Miguel Ingelmo
Primary Sjögren's syndrome in men: clinical and immunological characteristics.
Lupus 2000;9(1):61-4.
2000: J Rojas-Rodriguez; Mario Garcia-Carrasco; Manuel Ramos-Casals; G Enriquez-Coronel; C Colchero; Ricard Cervera; Josep Font
Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients.
The Journal of rheumatology 2000;27(1):238-40.
2000: Mauro Galeazzi; Pasquale Annunziata; gian domenico sebastiani; Francesca Bellisai; Valeria Campanella; Giovanni Battista Ferrara; Josep Font; Frédéric A Houssiau; Giuseppe Passiu; Enrique de Ramon Garrido; Antonio Fernandez-Nebro; Luisa Bracci; Raffaella Scorza; P Puddu; Anna Jedryka-Goral; Josef Smolen; Angela Tincani; Carlo Carcassi; Gabriella Morozzi; Roberto Marcolongo
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE.
The Journal of rheumatology 2000;27(1):135-41.
2000: Josep Font; Pilar Pizcueta; Manuel Ramos-Casals; Ricard Cervera; Mario García-Carrasco; M Navarro; Miguel Ingelmo; Pablo Engel
Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE).
Clinical and experimental immunology 2000;119(1):169-74.
1999: FJ Muñoz-Rodriguez; Josep Font; Ricard Cervera; Joan Carles Reverter; Dolors Tàssies; Gerard Espinosa; Alfonso López-Soto; Francisco Carmona; J Balasch; Antonio Ordinas; Miguel Ingelmo
Clinical study and follow-up of 100 patients with the antiphospholipid syndrome.
Seminars in arthritis and rheumatism 1999;29(3):182-90.
1999: Y Blanco; Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; Josep Font; Miguel Ingelmo
[Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
Revista clínica española 1999;199(9):586-8.
1999: Javier Calvo; Lourdes Places; G Espinosa; Olga Padilla; Josep Maria Vilà; N Villamor; Miguel Ingelmo; Teresa Gallart; Jordi Vives; Josep Font; Francisco Lozano
Identification of a natural soluble form of human CD5.
Tissue antigens 1999;54(2):128-37.
1999: Juan Balasch; Joan Carles Reverter; Montserrat Creus; Dolors Tàssies; Francisco Fábregues; Francisco Carmona; Josep Font; Juan A Vanrell
Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)
Human reproduction (Oxford, England) 1999;14(8):1956-9.
1999: Carlos Miret; Josep Font; Rafael Molina; Mario Garcia-Carrasco; Xavier Filella; M Ramos; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.
Anticancer research 1999;19(4B):3073-6.
1999: FJ Muñoz-Rodríguez; Dolors Tàssies; Josep Font; Joan Carles Reverter; Ricard Cervera; José M Sánchez-Tapias; Roberto Mazzara; Antonio Ordinas; Miguel Ingelmo
Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome.
Journal of hepatology 1999;30(5):770-3.
1999: Ricard Cervera; Munther A Khamashta; Josep Font; gian domenico sebastiani; A Gil; P Lavilla; A O Aydintug; Anna Jedryka-Góral; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; H J Haga; Alessandro Mathieu; Frédéric A Houssiau; G Ruiz-Irastorza; Miguel Ingelmo; G R V Hughes
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.
Medicine 1999;78(3):167-75.
1999: A Montehermoso; Ricard Cervera; Josep Font; Manuel Ramos-Casals; Mario García-Carrasco; F Formiga; JL Callejas; M Jorfán; M C Griñó; Miguel Ingelmo
Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus.
Seminars in arthritis and rheumatism 1999;28(5):326-32.
1999: gian domenico sebastiani; Mauro Galeazzi; Angela Tincani; Jean-Charles Piette; Josep Font; Flavio Allegri; Alessandro Mathieu; Josef Smolen; Enrique de Ramon Garrido; Antonio Fernandez-Nebro; Anna Jedryka-Goral; Chryssa Papasteriades; Gabriella Morozzi; Francesca Bellisai; O De Pitá; Roberto Marcolongo
Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.
Scandinavian journal of rheumatology 1999;28(6):344-51.
1999: José Mascaró; Juan Ferrando; M T Solé; Mercè Alsina; H C Nousari; Grant J Anhalt; Josep Font; J M Mascaró
Paraneoplastic pemphigus: a case of long-term survival associated with systemic lupus erythematosus and polymyositis.
Dermatology (Basel, Switzerland) 1999;199(1):63-6.
1999: X Bosch; Josep Font
The pulmonary-renal syndrome: a poorly understood clinicopathologic condition.
Lupus 1999;8(4):258-62.
1999: Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; Josep Font
Sjögren's syndrome and hepatitis C virus.
Clinical rheumatology 1999;18(2):93-100.
1999: RM Morlà; Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; Josep Font; M Bruguera; Jorge Rojas-Rodríguez; Miguel Ingelmo
Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature.
Lupus 1999;8(2):160-3.
1999: Mario García-Carrasco; Ricard Cervera; José Rosas; Manuel Ramos-Casals; RM Morlà; Antoni Sisó Almirall; Sònia Jiménez; Lucio Pallarés; Josep Font; Miguel Ingelmo
Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics.
Lupus 1999;8(1):20-3.
1998: Josep Font; Manuel Ramos-Casals; Ricard Cervera; X Bosch; E Mirapeix; Mario García-Carrasco; RM Morlà; Miguel Ingelmo
Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance.
British journal of rheumatology 1998;37(12):1287-91.
1998: Manuel Ramos-Casals; Ricard Cervera; Jordi Yagüe; Mario García-Carrasco; Olga Trejo; Sònia Jiménez; RM Morlà; Josep Font; Miguel Ingelmo
Cryoglobulinemia in primary Sjögren's syndrome: prevalence and clinical characteristics in a series of 115 patients.
Seminars in arthritis and rheumatism 1998;28(3):200-5.
1998: Josep Font; Ricard Cervera; G Espinosa; Lucio Pallarés; Manuel Ramos-Casals; S Jiménez; Mario García-Carrasco; L Seisdedos; Miguel Ingelmo
Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults.
Annals of the rheumatic diseases 1998;57(8):456-9.
1998: Joan Carles Reverter; Dolors Tàssies; Josep Font; Munther A Khamashta; K Ichikawa; Ricard Cervera; Gines Escolar; G R V Hughes; Miguel Ingelmo; Antonio Ordinas
Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes.
Arthritis and rheumatism 1998;41(8):1420-7.
1998: R A Asherson; Ricard Cervera; J C Piette; Josep Font; J T Lie; A Burcoglu; K Lim; FJ Muñoz-Rodríguez; Roger levy; F Boué; J Rossert; Miguel Ingelmo
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
Medicine 1998;77(3):195-207.
1998: Carlos Miret; Josep Font; Rafael Molina; Xavier Filella; J Vivancos; FJ Muñoz-Rodriguez; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.
Anticancer research 1998;18(2B):1341-4.
1998: J Ara; J Vivancos; J Soler-Carrillo; J C Paré; Ricard Cervera; Josep Font
Hypertrophic cardiomyopathy and systemic lupus erythematosus.
Clinical rheumatology 1998;17(6):531-3.
1998: Manuel Ramos-Casals; Ricard Cervera; Josep Font; Mario García-Carrasco; G Espinosa; S Reino; Lucio Pallarés; Miguel Ingelmo
Young onset of primary Sjögren's syndrome: clinical and immunological characteristics.
Lupus 1998;7(3):202-6.
1998: Josep Font; Dolors Tàssies; Mario García-Carrasco; Manuel Ramos-Casals; Ricard Cervera; Joan Carles Reverter; José M Sánchez-Tapias; Roberto Mazzara; Miguel Ingelmo
Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients.
Annals of the rheumatic diseases 1998;57(1):42-4.
1998: M Jorfén; JL Callejas; F Formiga; Ricard Cervera; Josep Font; Miguel Ingelmo
Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus.
Scandinavian journal of rheumatology 1998;27(1):76-7.
1997: S Reino; FJ Muñoz-Rodriguez; Ricard Cervera; Gerard Espinosa; Josep Font; Miguel Ingelmo
Optic neuropathy in the "primary" antiphospholipid syndrome: report of a case and review of the literature.
Clinical rheumatology 1997;16(6):629-31.
1997: Carlos Miret; Ricard Cervera; Joan Carles Reverter; Mario García-Carrasco; M Ramos; Meritxell Mollà; Josep Font; Miguel Ingelmo
Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
Clinical and experimental rheumatology 1997;15(5):541-4.
1997: Ricard Cervera; Mario García-Carrasco; Josep Font; M Ramos; Joan Carles Reverter; FJ Muñoz; Carlos Miret; Gerard Espinosa; Miguel Ingelmo
Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
Clinical and experimental rheumatology 1997;15(4):361-5.
1997: M Ramos; Ricard Cervera; Mario García-Carrasco; Carlos Miret; FJ Muñoz; Gerard Espinosa; Josep Font; Miguel Ingelmo
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Medicina clínica 1997;108(17):652-7.
1997: Ricard Cervera; Ronald A Asherson; Josep Font; Mohammed Tikly; Lucio Pallarés; A Chamorro; Miguel Ingelmo
Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature.
Medicine 1997;76(3):203-12.
1997: Josep Font; Alfonso López-Soto; Ricard Cervera; F J Casals; Joan Carles Reverter; FJ Muñoz; Carlos Miret; Albert Bové; Antonio Ordinas; Miguel Ingelmo
Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients.
Thrombosis research 1997;86(1):37-48.
1997: Alfonso López-Soto; Ricard Cervera; Josep Font; Albert Bové; Joan Carles Reverter; FJ Muñoz; Carlos Miret; Gerard Espinosa; Antonio Ordinas; Miguel Ingelmo
Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
Clinical and experimental rheumatology 1997;15(2):143-9.
1997: Mario García-Carrasco; M Ramos; Ricard Cervera; Josep Font; J Vidal; FJ Muñoz; Carlos Miret; Gerard Espinosa; Miguel Ingelmo
Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients.
Annals of the rheumatic diseases 1997;56(3):173-5.
1997: M Navarro; Ricard Cervera; Josep Font; Joan Carles Reverter; Joan Monteagudo; Gines Escolar; Alfonso López-Soto; Antonio Ordinas; Miguel Ingelmo
Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance.
Lupus 1997;6(6):521-6.
1997: FJ Muñoz-Rodríguez; Josep Font; Joan Ramon Badia; Carlos Miret; Joan A Barberà; Ricard Cervera; Miguel Ingelmo
Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.
Lupus 1997;6(4):412-4.
1997: M Teixidó; Josep Font; Joan Carles Reverter; Ricard Cervera; Dolors Tàssies; Miguel Ingelmo; Gines Escolar; Antonio Ordinas
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
British journal of rheumatology 1997;36(1):113-6.
1997: L Seisdedos; FJ Muñoz-Rodríguez; Ricard Cervera; Josep Font; Miguel Ingelmo
Primary antiphospholipid syndrome evolving into systemic lupus erythematosus.
Lupus 1997;6(3):285-6.
1996: Maria C Cid; Joan Monteagudo; J Oristrell; Jaime Vilaseca; L Pallarés; Ricard Cervera; Carme Font; Josep Font; Miguel Ingelmo; Alvaro Urbano-Márquez
Von Willebrand factor in the outcome of temporal arteritis.
Annals of the rheumatic diseases 1996;55(12):927-30.
1996: Joan Carles Reverter; Dolors Tàssies; Josep Font; Joan Monteagudo; Gines Escolar; Miguel Ingelmo; Antonio Ordinas
Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(11):1319-26.
1996: Juan Balasch; Montserrat Creus; Francisco Fábregues; Joan Carles Reverter; Francisco Carmona; Dolors Tàssies; Josep Font; Juan A Vanrell
Antiphospholipid antibodies and human reproductive failure.
Human reproduction (Oxford, England) 1996;11(10):2310-5.
1996: M Navarro; Ricard Cervera; M Teixidó; Joan Carles Reverter; Josep Font; Alfonso López-Soto; Joan Monteagudo; Gines Escolar; Miguel Ingelmo
Antibodies to endothelial cells and to beta 2-glycoprotein I in the antiphospholipid syndrome: prevalence and isotype distribution.
British journal of rheumatology 1996;35(6):523-8.
1996: Raimon Sanmartí; Antonio Collado; Jordi Gratacós; B E Herrera; Josep Font; Juan D Cañete; C Orellana; José Muñoz-Gomez
Reduced serum creatine kinase activity in inflammatory rheumatic diseases.
The Journal of rheumatology 1996;23(2):310-2.
1995: J Vivancos; J Soler-Carrillo; J Ara-del Rey; Josep Font
Development of polyarteritis nodosa in the course of inactive systemic lupus erythematosus.
Lupus 1995;4(6):494-5.
1995: Xavier Bosch; J Llena; Antonio Collado; Josep Font; Eduard Mirapeix; Miguel Ingelmo; José Muñoz-Gómez; Alvaro Urbano-Márquez
Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
The Journal of rheumatology 1995;22(11):2038-45.
1995: C Orellana; Antonio Collado; M V Hernandez; Josep Font; J A Del Olmo; José Muñoz-Gomez
When does amyloidosis complicate systemic lupus erythematosus?
Lupus 1995;4(5):415-7.
1995: M R Pino-Otín; Octavi Viñas; M A de la Fuente; Manel Juan; Josep Font; M Torradeflot; L Pallarés; Francisco Lozano; J Alberola-Ila; Jaume Martorell
Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patients.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(6):3015-24.
1995: Josep Font; Josep Vidal; Ricard Cervera; Alfonso López-Soto; Carlos Miret; M Teresa Jiménez de Anta; Miguel Ingelmo
Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosus.
Lupus 1995;4(1):47-9.
1995: Joan Carles Reverter; Dolors Tàssies; Gines Escolar; Josep Font; Alfonso López-Soto; Miguel Ingelmo; Antonio Ordinas
Effect of plasma from patients with primary antiphospholipid syndrome on platelet function in a collagen rich perfusion system.
Thrombosis and haemostasis 1995;73(1):132-7.
1994: Juan Balasch; Josep Font
Antiphospholipid antibody testing in patients with pregnancy loss.
Lupus 1994;3(5):429-31.
1994: Xavier Bosch; Alfonso López-Soto; Eduard Mirapeix; Josep Font; Miguel Ingelmo; Alvaro Urbano-Márquez
Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage.
Archives of pathology & laboratory medicine 1994;118(5):517-22.
1994: J Vivancos; Alfonso López-Soto; Josep Font; J Balasch; Ricard Cervera; Joan Carles Reverter; Francisco Carmona; Miguel Ingelmo
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases].
Medicina clínica 1994;102(15):561-5.
1994: Ricard Cervera; M Navarro; Alfonso López-Soto; Maria C Cid; Josep Font; J Esparza; Joan Carles Reverter; Joan Monteagudo; Miguel Ingelmo; Alvaro Urbano-Márquez
Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.
Annals of the rheumatic diseases 1994;53(4):265-7.
1994: Xavier Bosch; Eduard Mirapeix; Josep Font; Alfonso López-Soto; R Rodríguez; J Vivancos; L Revert; Miguel Ingelmo; Alvaro Urbano-Márquez
[Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
Medicina clínica 1994;102(11):412-7.
1993: Juan Balasch; Francisco Carmona; Alfonso López-Soto; Josep Font; Montserrat Creus; Francisco Fábregues; M Ingelmo; Juan A Vanrell
Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome.
Human reproduction (Oxford, England) 1993;8(12):2234-9.
1993: Josep Font; Ricard Cervera
1982 revised criteria for classification of systemic lupus erythematosus--ten years later.
Lupus 1993;2(5):339-41; discussion 343.
1993: Josep Font; L Pallarés; Ricard Cervera; J Vivancos; Alfonso López-Soto; C Herrero; Alejandro Darnell; A Torras; Eduard Mirapeix; J A del Olmo
[Systemic lupus erythematosus: a clinical and immunological study of 300 patients].
Medicina clínica 1993;100(16):601-5.
1993: X Forns; X Bosch; F Graus; M Navarro; Josep Font
Amyotrophic lateral sclerosis in a patient with systemic lupus erythematosus.
Lupus 1993;2(2):133-4.
1993: Ricard Cervera; Munther A Khamashta; Josep Font; gian domenico sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.
Medicine 1993;72(2):113-24.
1993: David D'Cruz; Ricard Cervera; A Olcay Aydintug; T Ahmed; Josep Font; G R V Hughes
Systemic lupus erythematosus evolving into systemic vasculitis: a report of five cases.
British journal of rheumatology 1993;32(2):154-7.
1993: Xavier Bosch; J Llena; Josep Font; Antonio Collado; Eduard Mirapeix; Alvaro Urbano-Márquez; Miguel Ingelmo
Anti-granulocyte perinuclear antibodies but not anti-neutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis.
Advances in experimental medicine and biology 1993;336():375-80.
1993: Xavier Bosch; Josep Font; Eduard Mirapeix; L Revert; Alvaro Urbano-Márquez; Miguel Ingelmo
Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations.
Advances in experimental medicine and biology 1993;336():281-6.
1992: Josep Font; Ricard Cervera; M Navarro; L Pallarés; Alfonso López-Soto; J Vivancos; Miguel Ingelmo
Systemic lupus erythematosus in men: clinical and immunological characteristics.
Annals of the rheumatic diseases 1992;51(9):1050-2.
1992: Xavier Bosch; Eduard Mirapeix; Josep Font; Ricard Cervera; Miguel Ingelmo; Munther A Khamashta; L Revert; G R Hughes; Alvaro Urbano-Márquez
Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1992;20(3):231-9.
1992: J Vivancos; Xavier Bosch; Josep M Grau; A Coca; Josep Font
Development of Hodgkin's disease in the course of primary Sjögren's syndrome.
British journal of rheumatology 1992;31(8):561-3.
1992: R A Asherson; Ricard Cervera; Josep Font
Multiorgan thrombotic disorders in systemic lupus erythematosus: a common link?
Lupus 1992;1(4):199-203.
1992: Xavier Bosch; Josep Font; Eduard Mirapeix
[Anti-neutrophil cytoplasmic antibodies].
Medicina clínica 1992;98(9):348-54.
1992: J Montalbán; Ricard Cervera; Josep Font; J Ordi; J Vianna; Hans-Jacob Haga; Mar Tintoré; Munther A Khamashta; G R V Hughes
Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus.
Neurology 1992;42(3 Pt 1):681-2.
1992: Ricard Cervera; Josep Font; Carles Paré; Manel Azqueta; F Pérez-Villa; Alfonso López-Soto; Miguel Ingelmo
Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.
Annals of the rheumatic diseases 1992;51(2):156-9.
1991: Xavier Bosch; X Forns; Josep Font; Eduard Mirapeix; L Revert; Miguel Ingelmo
[Neutrophil anticytoplasmic antibodies in a patient with Wegener's granulomatosis: therapeutic implications of its detection and relation to clinical activity].
Medicina clínica 1991;97(20):780-2.
1991: Ricard Cervera; Munther A Khamashta; Josep Font; P A Reyes; J L Vianna; Alfonso López-Soto; M C Amigo; R A Asherson; Manel Azqueta; Carles Paré
High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome.
Lupus 1991;1(1):43-7.
1991: Juan Balasch; Alfonso López-Soto; Josep Font; Bienvenido Puerto
Lupus anticoagulant as a marker of autoimmunity in recurrent pregnancy loss; a case report.
European journal of obstetrics, gynecology, and reproductive biology 1991;41(3):237-41.
1991: Josep Font; L Pallarés; Ricard Cervera; Alfonso López-Soto; M Navarro; Xavier Bosch; Miguel Ingelmo
Systemic lupus erythematosus in the elderly: clinical and immunological characteristics.
Annals of the rheumatic diseases 1991;50(10):702-5.
1991: X Bosch; A G Agustí; Josep Font; J Roca; A López-Soto; Miguel Ingelmo; R Rodríguez-Roisín
[An elevated prevalence of subclinical pulmonary involvement in systemic lupus erythematosus].
Revista clínica española 1991;189(5):203-8.
1991: I Bielsa; Carmen Herrero; G Ercilla; Antonio Collado; Josep Font; Miguel Ingelmo; José Mascaró
Immunogenetic findings in cutaneous lupus erythematosus.
Journal of the American Academy of Dermatology 1991;25(2 Pt 1):251-7.
1991: Josep Font; Ricard Cervera; Carles Paré; Alfonso López-Soto; L Pallarés; Manel Azqueta; Munther A Khamashta
Non-infective verrucous endocarditis in a patient with 'primary' antiphospholipid syndrome.
British journal of rheumatology 1991;30(4):305-7.
1991: Ricard Cervera; Munther A Khamashta; Josep Font; G Ramírez; David D'Cruz; J Montalbán; Alfonso López-Soto; R A Asherson; Miguel Ingelmo; G R V Hughes
Antiendothelial cell antibodies in patients with the antiphospholipid syndrome.
Autoimmunity 1991;11(1):1-6.
1991: Josep Font; Alfonso López-Soto; Ricard Cervera; Juan Balasch; L Pallarés; M Navarro; Xavier Bosch; Miguel Ingelmo
The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.
Autoimmunity 1991;9(1):69-75.
1990: J Valls-Sole; Francesc Graus; Josep Font; A Pou; Eduardo Tolosa
Normal proprioceptive trigeminal afferents in patients with Sjögren's syndrome and sensory neuronopathy.
Annals of neurology 1990;28(6):786-90.
1990: Josep Font; J Valls; Ricard Cervera; A Pou; Miguel Ingelmo; Francesc Graus
Pure sensory neuropathy in patients with primary Sjögren's syndrome: clinical, immunological, and electromyographic findings.
Annals of the rheumatic diseases 1990;49(10):775-8.
1990: Maria C Cid; Ricard Cervera; Josep Font; A Lopez-Soto; L Pallarés; M Navarro; Miguel Ingelmo
Late thrombotic events in patients with temporal arteritis and anticardiolipin antibodies.
Clinical and experimental rheumatology 1990;8(4):359-63.
1990: Munther A Khamashta; Ricard Cervera; R A Asherson; Josep Font; A Gil; D J Coltart; J J Vázquez; Carles Paré; Miguel Ingelmo; J Oliver
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus.
Lancet 1990;335(8705):1541-4.
1990: J Vivancos; Xavier Bosch; Alfonso López-Soto; Josep Font; J M Ribera; Miguel Ingelmo
Giant cell arteritis presenting as a supraclavicular nodule.
Annals of the rheumatic diseases 1990;49(3):202-3.
1990: Josep Font; Carmen Herrero; X Bosch; R Cervera; Miguel Ingelmo; José Mascaró
Systemic lupus erythematosus in a patient with partial lipodystrophy.
Journal of the American Academy of Dermatology 1990;22(2 Pt 2):337-40.
1990: Ricard Cervera; Josep Font; Alfonso López-Soto; F Casals; L Pallarés; Albert Bové; Miguel Ingelmo; Alvaro Urbano-Márquez
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.
Annals of the rheumatic diseases 1990;49(2):109-13.
1990: Juan Balasch; Josep Font; Alfonso López-Soto; Ricard Cervera; I Jové; F J Casals; Juan A Vanrell
Antiphospholipid antibodies in unselected patients with repeated abortion.
Human reproduction (Oxford, England) 1990;5(1):43-6.
1989: Josep Font; Ricard Cervera; A Lopez-Soto; L Pallares; Xavier Bosch; S Ampurdanes; F J Casals; Miguel Ingelmo
Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations.
Clinical rheumatology 1989;8(4):475-83.
1989: Jaume Martorell; Josep Font; Isabel Rojo; Ramón Vilella; Miguel Ingelmo; Jordi Vives
Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
Clinical and experimental immunology 1989;78(2):172-6.
1989: Alfonso López-Soto; F J Casals; Josep Font; Ricard Cervera; Miguel Ingelmo
Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen.
Thrombosis research 1989;53(6):623-8.
1988: Carmen Herrero; I Bielsa; Josep Font; F Lozano; G Ercilla; Mario Lecha; Miguel Ingelmo; José Mascaró
Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases.
Journal of the American Academy of Dermatology 1988;19(6):1057-62.
1988: Josep Font; Ricard Cervera; L Pallarés; Alfonso López-Soto; Miguel Ingelmo
Systemic lupus erythematosus and monoclonal gammopathy.
British journal of rheumatology 1988;27(5):412-3.
1988: L Pallarés; Josep Font; A López-Soto; Miguel Ingelmo
[Late-onset systemic lupus erythematosus].
Revista clínica española 1988;183(5):253-4.
1988: Alfonso López-Soto; Josep Font; L Pallarés; Miguel Ingelmo
[Lupus myocarditis with severe heart insufficiency].
Medicina clínica 1988;91(7):277.
1988: Josep Font; Ricard Cervera; F J Casals; Albert Bové; A Guerrero; Alfonso López-Soto; Miguel Ingelmo; Alvaro Urbano-Márquez
[Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus].
Medicina clínica 1988;90(12):490-3.
1987: Josep Font; Ricard Cervera; Albert Bové; F J Casals
[Antiphospholipid antibodies as markers of systemic lupus erythematosus].
Medicina clínica 1987;89(12):528.
1987: I Bielsa; Carmen Herrero; Josep Font; José Mascaró
Lupus erythematosus and toxic epidermal necrolysis.
Journal of the American Academy of Dermatology 1987;16(6):1265-7.
1987: Josep Font; F J Casals; Ricard Cervera; Albert Bové
[Anticardiolipin antibodies and thrombosis in systemic lupus erythematosus].
Medicina clínica 1987;89(1):41.
1985: C Herrero; Josep Font; I Bielsa; A Coca
[Treatment of Sweet's syndrome using potassium iodate].
Medicina clínica 1985;84(5):209.